거래 정지 중인 종목 2026-06-04 이후 거래가 정지되었습니다. 재개될 수 있으며, 표시된 시세는 마지막 거래일 기준입니다.
CASI
Careside Inc
$0.21
+0.00 +0.00%
케어사이드(CASI) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
시가총액
$3M
스몰캡
P/E
-
배당수익률
없음
52주 위치
0%
저점 +0% · 고점 -93%
애널리스트
-
F
Fundamental health
vs. 전체 시장· based on 1 axes
수익성 데이터 부족
성장 Top 78%
밸류에이션 데이터 부족
재무 안정 데이터 부족
| Index | - | P/E | - | EPS (ttm) | -3.02 | Insider Own | 87.27% | Shs Outstand | 15.5M | Perf Week | - |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 9.3M | Perf Month | -73.05% |
| Enterprise Value | - | PEG | - | EPS next Q | -0.36 | Inst Own | 32.6% | Short Float | 0.98% | Perf Quarter | -75.4% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.45 | Perf Half Y | -91.09% |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | 0.09M | Perf YTD | -75.59% |
| Book/sh | - | P/C | - | EPS past 3/5Y | 1.69% - | ROE | - | 52W High | -93.28% ($3.09) | Perf Year | -91.09% |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | -1.67% - | ROIC | - | 52W Low | 0% ($0.21) | Perf 3Y | -88.96% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -42.26% | Gross Margin | - | Volatility(W/M) | 24.09% 13.06% | Perf 5Y | -99.17% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | 26.2% | Oper. Margin | - | ATR (14) | 0.12 | Perf 10Y | -97.5% |
| Dividend Ex-Date | - | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | 18.41 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | - | Sales Q/Q | -60.5% | SMA20 | -75.33% ($0.85) | Beta | 1.01 | Target Price | $4 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -76.46% ($0.89) | Rel Volume | 0 | Prev Close | $0.21 |
| Employees | 233 | LT Debt/Eq | - | EPS/Sales Surpr. | -70% - | SMA200 | -85.7% ($1.47) | Avg Volume(3M) | 0.20M | Price | $0.21 |
| IPO | 1996/6/12 | Option/Short | No/No | Trades | 0 | Volume | - | Change | - |
Quarterly earnings trend Quarterly earnings data is not yet available — foreign-listed companies (ADRs) only file annual reports with the U.S., and recently listed companies may not have filed their first quarterly report.
Careside Inc (CASI) Investment Analysis
What kind of company is Careside Inc?
케어사이드(CASI)
Healthcare · Biotechnology
Small-Cap — Low Volume, High Volatility
💊 CareSide (ticker CASI) is a clinical-stage biopharmaceutical company developing and commercializing oncology and immunology drugs, with a primary focus on the U.S. and Chinese markets. Its core pipeline centers on an anti-CD38 monoclonal antibody candidate, and its revenue structure combines product sales from already-approved oncology therapies. The company falls within the micro-cap category given its relatively small market capitalization, and its share price tends to exhibit significant volatility depending on clinical development progress and funding conditions.
Learn more about Careside Inc →Market Cap
$0.0B
Approx. KRW 0.0 trillion
⚖️ 0% of Samsung Electronics
Market Cap Rank5742
Employees233people
IPO1996/06/12
Current Price$0.21 ≈ 288원
Key Events
예정된 이벤트가 없습니다
CASI의 다음 실적 발표일이나 배당 일정이 아직 수집되지 않았습니다.
- 실적 발표는 보통 분기마다 있습니다
- 배당주는 연 1~4회 배당락일이 있습니다
Is it profitable?
Financial metrics unavailable
Profitability and financial-health indicators have not yet been collected.
What's the outlook?
Mixed Outlook
Positive and negative signals are mixed
애널리스트 목표가
$4.00
현재가 대비 +1804.8%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.
Did earnings meet expectations?
Insufficient historical earnings data
No analyzable past earnings releases have been collected yet.
Is it growing?
Average Growth
Mid-range within the industry
📊 How much has it grown? (actual results)
Past 3-Year EPS
Actual average annual EPS growth over the past 3 years
+1.7%
평균
⚡ Short-term momentum
QoQ Revenue
Revenue change from the previous quarter (short-term momentum)
-60.5%
매우 부진
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.
New to investing terms? Look it up in the financial dictionary →
Has the stock risen over the long term?
Long-term weakness — -168%p below the market
CASI -99.2% · S&P 500 +68.8%
Excess return vs. market (price-based, ex-dividends)
5-year basis
vs S&P 500
-168.0%p
Significantly behind the market
vs Health Care (XLV)
-126.2%p
Significantly behind the sector average
1-year basis
vs S&P 500
-107.4%p
Significantly behind the market
vs Health Care (XLV)
-114.7%p
Significantly behind the sector average
Current position within 52-week range
Low (-0.0%p) High (-93.3%p)
Current price is 0.0% above the 52-week low and 93.3% below the 52-week high
Recent risk (last 36 trading days)
Max drawdown
-79.6%
Annualized volatility
362.1%
Is it attractive at this price?
Valuation data is insufficient
Key metrics such as PER and PBR are unavailable, so valuation is omitted.
Who owns it?
Ownership flow is positive
Short interest light 1.0% · Short interest fell -0.8%p over the last 36 days
📈 Recent trading flow (6 months)
🧑💼 Insiders (executives & directors)
0.0%
Insiders little change
🏦 Institutions (funds & investors)
-
No trading data for Institutions
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 32.6%
Moderate institutional participation
🧑💼 Insiders 87.3%
Founder/management large holders (strong skin-in-the-game)
👤 Retail investors (estimated) 0.0%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
1.0%
Low — limited short-side pressure
Past 36 days 📉 -0.8%p decrease
Short interest days to cover
0.5 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 15.5M주
Float (tradable shares) 9.3M주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 36 days.
How much does it pay in dividends?
This company does not pay a dividend
It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.
Compare Industry Peers
💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
| Stock | Market Cap | PER | PBR | ROE | Dividend Yield | Change |
|---|---|---|---|---|---|---|
| CASI This Stock | $3.2M | - | - | - | - | +0.0% |
LLY | $1.15T | 43.9 ▼ | 36.9 ▼ | 107.64% ▲ | 0.57% ▼ | +1.9% |
JNJ | $642.8B | 30.9 ▼ | 7.6 ▼ | 25.74% ▲ | 2.02% ▲ | +0.3% |
ABBV | $465.0B | 129.8 ▼ | - | 15221.82% ▲ | 2.61% ▲ | +2.5% |
UNH | $389.4B | 27.6 ▼ | 4.0 ▼ | 12.49% ▲ | 2.11% ▲ | +2.7% |
MRK | $325.6B | 37.1 ▼ | 7.1 ▼ | 18.97% ▲ | 2.48% ▲ | +0.8% |
| Sector Avg | - | 26.4 | 2.6 | -48.94% | 1.16% | - |
FAQ
What kind of company is 케어사이드(CASI)?
케어사이드(CASI) belongs to the Healthcare sector and operates in the Biotechnology industry.
What is the market cap of CASI?
The market cap of CASI is approximately $3M, ranking 5,742 within its sector.
What is the 52-week high and low for CASI?
CASI has recorded a 52-week high of $3.09 and a low of $0.21.
면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.